Skip to content
stoqly

CNO Financial Group

CNO NYSE Life & Health Insurance Financials FY2016–FY2025

CNO Financial Group's revenue rose 0.8% to $4.5 billion in fiscal 2025. Its operating margin was 12.3%, about the same as 12.4% a year earlier. It paid out $398 million in dividends and buybacks. The diluted share count fell 7.7%.

Last close · Oct 23, 2026

$53.66

3.3%
Value it Compare
Revenue Total sales reported in the income statement.
$4.5B
0.9% vs prior year
Operating margin Operating income as a share of revenue.
12.3%
0.1 pts
Net income Profit after all expenses, interest and tax.
$229M
45.5%
Free cash flow Cash from operations minus capital spending.
—
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
—
Market cap Last close times the latest diluted share count, so it is approximate.
$5.1B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
18.4x
On $2.91 EPS (TTM)

What CNO Financial Group does

No business description yet.

Legal name
CNO Financial Group, Inc.
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001224608-26-000017
0001224608

Revenue and margins

CNO Financial Group had $4.5B of revenue in fiscal 2025, up 0.9% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 1.5% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.

Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

CNO Financial Group returned $398M to shareholders in fiscal 2025. The diluted share count fell 7.7%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value CNO Financial Group yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of — and divides by 99.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 18.4x · peers 10.6x · sector 13.7x.

Balance sheet

Cash, debt and the ratios that show how comfortably CNO Financial Group can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $732M$645M$889M$2.0B$984M
Interest coverage 5.4x3.4x1.9x2.2x2.4x
Total assets $36.2B$33.1B$35.0B$37.8B$38.8B
Total liabilities $30.9B$31.4B$32.8B$35.3B$36.2B
Shareholders' equity $3.7B$1.8B$2.2B$2.5B$2.6B
Net debt (− = net cash) —————

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$7.6M

5 insiders

Of sales under plans

100%

$7.6M

DateInsiderTradeSharesPriceValueFiling
Sep 16, 2026 Jeremy D. WilliamsChief Actuary Sold plan 4,362 $55.71 $0.2M Form 4
Sep 15, 2026 Jeremy D. WilliamsChief Actuary Sold plan 4,420 $55.27 $0.2M Form 4
Sep 2, 2026 Jeanne L. LinnenbringerChief Operations Officer Sold plan 3,919 $55.11 $0.2M Form 4
Sep 2, 2026 Karen J. DeToroPresident, Worksite Division Sold plan 5,964 $55.12 $0.3M Form 4
Sep 1, 2026 Jeanne L. LinnenbringerChief Operations Officer Sold plan 4,060 $54.73 $0.2M Form 4
Sep 1, 2026 Karen J. DeToroPresident, Worksite Division Sold plan 9,336 $54.74 $0.5M Form 4
Aug 31, 2026 Jeanne L. LinnenbringerChief Operations Officer Sold plan 6,560 $54.99 $0.4M Form 4
Aug 31, 2026 Karen J. DeToroPresident, Worksite Division Sold plan 9,374 $54.98 $0.5M Form 4
Jul 1, 2026 Rocco F. Tarasi IIIChief Marketing Officer Sold plan 1,891 $51.31 $0.1M Form 4
Jun 30, 2026 Gary C. BhojwaniChief Executive Officer, Director Sold plan 86,048 $51.48 $4.4M Form 4
Jun 11, 2026 Rocco F. Tarasi IIIChief Marketing Officer Sold plan 5,750 $50.00 $0.3M Form 4
Jun 10, 2026 Rocco F. Tarasi IIIChief Marketing Officer Sold plan 3,308 $49.00 $0.2M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✓ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets — — —
Current ratio rose — — —
Share count didn't rise ✓ ✓ ✓
Gross margin rose — — —
Revenue rose relative to assets ✓ ✓ ✕
F-score — / 9— / 9— / 9
Accruals ratio −0.9%−0.6%−1.2%
Altman Z'' ———

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
CNO Financial Group CNO $5.1B 0.9% 12.3% — — 18.4x —
Globe Life GL $12.2B 3.7% — 20.9% 16.0% 10.3x — Compare →
Primerica PRI $8.6B 6.6% — — 34.5% 11.0x — Compare →
Brighthouse Financial BHF $2.6B 43.2% — — — 3.6x — Compare →
Unum UNM $14.4B 1.5% — 4.3% 7.6% 21.0x — Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $4.0B $4.3B $4.3B $4.0B $3.8B $4.1B $3.6B $4.1B $4.4B $4.5B
Operating income — $455M $381M $368M $464M $515M $467M $460M $551M $553M
Interest expense $116M $124M $150M $152M $109M $95.4M $137M $239M $254M $231M
Pretax income $353M $481M −$265M $274M $344M $733M $817M $357M $540M $293M
Income tax −$5.0M $305M $50.2M −$135M $42.5M $163M $186M $80.3M $119M $64.1M
Net income $358M $176M −$315M $409M $302M $570M $631M $277M $421M $229M
Diluted EPS $2.01 $1.02 −$1.90 $2.61 $2.11 $4.35 $5.36 $2.40 $3.89 $2.30
Diluted shares 0.18B 0.17B 0.17B 0.16B 0.14B 0.13B 0.12B 0.12B 0.11B 0.10B
Cash flow
Cash from operations $776M $633M $318M $697M $736M $598M $495M $583M $628M $676M
Depreciation and amortization $275M $265M $292M $268M $304M $237M $249M $267M $292M $319M
Acquisitions $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Share buybacks $210M $168M $108M $255M $268M $408M $190M $166M $300M $331M
Dividends paid $54.8M $59.6M $64.8M $67.1M $67.0M $65.7M $64.8M $68.1M $67.7M $66.2M
Dividends and buybacks $265M $228M $173M $322M $335M $474M $255M $234M $368M $398M
Balance sheet
Cash and short-term investments $668M $757M $657M $655M $992M $732M $645M $889M $2.0B $984M
Total debt $913M $915M $917M — — — — — — —
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Total assets $32.0B $33.1B $31.4B $33.6B $35.3B $36.2B $33.1B $35.0B $37.8B $38.8B
Total liabilities $27.5B $28.3B $28.1B $29.0B $29.9B $30.9B $31.4B $32.8B $35.3B $36.2B
Shareholders' equity $4.5B $4.8B $3.4B $4.7B $5.5B $3.7B $1.8B $2.2B $2.5B $2.6B
Margins
Operating margin — 10.6% 8.8% 9.2% 12.1% 12.5% 13.1% 11.1% 12.4% 12.3%
EBITDA margin 18.7% 16.8% 15.6% 15.8% 20.1% 18.2% 20.0% 17.5% 19.0% 19.4%
Net margin 9.0% 4.1% −7.3% 10.2% 7.9% 13.8% 17.6% 6.7% 9.5% 5.1%
Returns
Return on capital 10.4% 4.7% 7.0% — — — — — — —
Return on equity 8.3% 3.8% −7.7% 10.2% 5.9% 12.4% 23.1% 13.9% 17.8% 8.9%
Return on assets 1.1% 0.5% −1.0% 1.3% 0.9% 1.6% 1.8% 0.8% 1.2% 0.6%
Growth
Revenue growth 4.5% 7.8% 0.4% −6.9% −4.9% 7.9% −13.2% 15.9% 7.3% 0.9%
Net income growth 32.3% −51.0% −279.4% — −26.3% 89.0% 10.6% −56.2% 52.2% −45.5%
EPS growth 44.6% −49.3% −286.3% — −19.2% 106.2% 23.2% −55.2% 62.1% −40.9%
Share count change −8.6% −3.5% −3.9% −5.0% −8.9% −8.4% −10.2% −2.2% −6.1% −7.7%
Financial health
Net debt / EBITDA 0.3x 0.2x 0.4x — — — — — — —
Debt / equity 0.2x 0.2x 0.3x — — — — — — —
Interest coverage 4.0x 3.7x 2.5x 2.4x 4.3x 5.4x 3.4x 1.9x 2.2x 2.4x
Quality scores
Accruals ratio −1.3% −1.4% −2.0% −0.9% −1.3% −0.1% 0.4% −0.9% −0.6% −1.2%

Source: SEC EDGAR XBRL filings (CIK 0001224608). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open